How the Vaccine Industry and Biotechs Can Accelerate Pandemic Responses

by Alex Dale | February 19, 2021

shutterstock_1782359774

The impact of the Covid-19 pandemic has highlighted the need for a fast and effective vaccine development process. How the Vaccine Industry and Biotechs Can Accelerate Pandemic Responses’ discusses various technologies and approaches that could drive the vaccine industry forward, helping it to tackle ongoing and future pandemics.

 

New and improved vaccine platforms will enhance the tools at the disposal of vaccine developers. mRNA is emerging as a powerful vaccine platform, while viral vectors were established as a vaccine platform in response to the 2014 Ebola outbreak. Although there are benefits to both technologies, they also have areas for improvement.

 

Stringent safety regulations are a bottleneck during vaccine development, of which biosafety testing is an important part. New platforms are being developed that offer faster and more sensitive testing, which could help vaccine developers to reach the clinic sooner.

 

Collaborating with biotechs is encouraged to make use of their creativity and scientific expertise. In return, the Life Science industry can support biotechs with access to technologies that accelerate timelines and guidance as they interact with authorities to obtain regulatory approval.

 

Experts at

MilliporeSigma
Merck
  give insight into each of these areas and highlight the products, services, and expertise that the company can provide to support vaccine developers.

[molongui_author_box]

Related Posts

Hiring Challenges in Bioprocessing for Start-ups

Creating Bottlenecks in Europe; Opportunities for Production Staff BioPlan Associates, Inc. Hiring of bioprocessing professionals has remained a…

When to sprint and when to breathe in the race from lab to clinic – 5 critical steps to success

As an early-stage or small-sized biotech company, you need to move fast and be nimble.  Success is measured…

Starting your journey into manufacturing – choosing a cell line development provider

One of the biggest decisions which any company developing biological medicines makes is to move forward to the manufacture of their product. …

A Streamlined Approach to Analytical Method Development and Implementation

The development and implementation of analytical methods are essential for success at all phases of a molecule’s journey,…

Scroll to Top